Thermodynamic stability considerations for isostructural dehydrates

Journal of Pharmaceutical Sciences

Volumn 101, Issue 4, 2012, Pages 1486-1495

  Murphy, Brendan J ^a   Casteel, Melissa J ^a   Samas, Brian ^a   Krzyzaniak, Joseph F ^a  

^a PFIZER INC   (United States)

Author keywords

Clathratesl; Crystal polymorphism; Crystal structure; Crystals; Hydrate; Hydrates solvates; Hydration; Stability; Thermal analysis; Thermodynamics

Indexed keywords

NONSTOICHIOMETRIC COMPOUND;

ARTICLE; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; LOW TEMPERATURE; MELTING POINT; ROOM TEMPERATURE; SOLID STATE; THERMODYNAMICS; TRANSITION TEMPERATURE;

EID: 84857505249     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23037     Document Type: Article

References (20)

1. Grant DJW. 1999. Theory and origin of polymorphism. In Polymorphism in pharmaceutical solids; Brittain HG, Ed. New York: Marcel Dekker, pp 1-31.
2. Haleblian JK, McCrone W. 1969. Pharmaceutical applications of polymorphism. J Pharm Sci 58:911-929.
3. Gu CH, Young V Jr, Grant DJW. 2001. Polymorph screening: Influence of solvents on the rate of solvent-mediated polymorphic transformation. J Pharm Sci 90:1878-1890.
4. Miller JM, Collman BM, Greene LR, Grant DJW, Blackburn AC. 2005. Identifying the stable polymorph early in the drug discovery-development process. Pharm Dev Technol 10:291-297.
5. Krzyzaniak JF, Williams GR, Ni N. 2007. Identification of phase boundaries in anhydrate/hydrate systems. J Pharm Sci 96:1270-1281.
6. Ticehurst MD, Storey RA, Watt C. 2002. Application of slurry bridging experiments at controlled water activities to predict the solid-state conversion between anhydrous and hydrated forms using theophylline as a model drug. Int J Pharm 247:1-10.
7. Yu L. 1995. Inferring thermodynamic stability relationship of polymorphs from melting data. J Pharm Sci 84:966-974.
8. Yu L, Huang J, Jones KJ. 2005. Measuring free-energy difference between crystal polymorphs through eutectic melting. J Phys Chem B 109:19915-19922.
9. Murphy BJ, Huang J, Casteel MJ, Cobani A, Krzyzaniak JF. 2010. Varenicline l-tartrate crystal forms: Characterization through crystallography, spectroscopy and thermodynamics. J Pharm Sci 99:2766-2776.
10. Vippagunta SR, Brittain HG, Grant DJW. 2001. Crystalline solids. Adv Drug Deliv Rev 43:3-26.
11. Stephenson GA, Groleau EG, Kleemann RL, Xu W, Rigsbee DR. 1998. Formation of isomorphic desolvates: Creating a molecular vacuum. J Pharm Sci 87:536-542.
12. Yu LJ, Chen Y, Treadway JL, McPherson RK, McCoid SC, Gibbs EM, Hoover DJ. 2006. Establishment of correlation between in vitro enzyme binding potency and in vivo pharmacological activity: Application to liver glycogen phosphorylase a inhibitors. J Pharmacol Exp Ther 317:1230-1237.
13. Greenspan L. 1977. Humidity fixed points of binary saturated aqueous solutions. J Res Nat Bur Stand 81A:89-96.
14. 2 in nonporous hydrophobic clarithromycin form II crystals. J Am Chem Soc 131:13216-13217.
15. Apperley DC, Basford PA, Dallman CI, Harris RK, Kinns M, Marshall PV, Swanson AG. 2005. Nuclear magnetic resonance investigation of the interaction of water vapor with sildenafil citrate in the solid state. J Pharm Sci 94:516-523.
16. 1) hydrates: Part 1. J Pharm Sci 99:816-826.
17. Vogt FG, Dell'Orco PC, Diederich AM, Su Q, Wood JL, Zuber GE, Katrincic LM, Mueller RL, Busby DJ, DeBrosse CW. 2006. A study of variable hydration states in topotecan hydrochloride. J Pharm Biomed Anal 40:1080-1088.
18. Stephenson GA, Stowell JG, Toma PH, Pfeiffer RR, Byrn SR. 1997. Solid-state investigation of erythromycin a dihydrate: Structure, NMR spectroscopy, and hygroscopicity. J Pharm Sci 86:1239-1244.
19. Variankaval N, Lee C, Xu J, Calabria R, Tsou N, Ball R. 2007. Water activity-mediated control of crystalline phases of an active pharmaceutical ingredient. Org Process Res Dev 11:229-236.
20. Burger A, Ramberger R. 1979. On the polymorphism of pharmaceuticals and other molecular crystals. I. Theory of thermodynamic rules. II. Applicability of thermodynamic rules. Mikrochim Acta 2:259-271, 273-316.